Lehman Financial Resources’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Lehman Financial Resources’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-600	Closed	-$27K	–	259
2015 Q3	$27K	Hold	600	–	–	0.01%	215
2015 Q2	$35K	Hold	600	–	–	0.02%	192
2015 Q1	$33K	Hold	600	–	–	0.02%	201
2014 Q4	$30K	Hold	600	–	–	0.01%	191
2014 Q3	$28K	Hold	600	–	–	0.01%	198
2014 Q2	$26K	Hold	600	–	–	0.01%	202
2014 Q1	$25K	Hold	600	–	–	0.01%	198
2013 Q4	$22K	Hold	600	–	–	0.01%	206
2013 Q3	$21K	Hold	600	–	–	0.01%	200
2013 Q2	$17K	Buy	+600	New	+$17.1K	0.01%	193

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

TAM

Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return

Quantitative Advantage Minnetonka, Minnesota $689M AUM 6.25% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lehman Financial Resources's PBE Position: Q4 2015 in Review

Lehman Financial Resources sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2015, closing a stake of 600 shares — an estimated $27K sold.

Lehman Financial Resources first reported a position in PBE in Q2 2013 and held it in 10 quarters. The position peaked at $35K in Q2 2015. 86 funds tracked by Wall St. Rank hold PBE as of Q4 2015.

Lehman Financial Resources reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2015 after selling out during the quarter.
Lehman Financial Resources sold 600 Invesco Biotechnology & Genome ETF shares in Q4 2015, an estimated $27K.
Lehman Financial Resources first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and held it in 10 quarters.
Lehman Financial Resources's Invesco Biotechnology & Genome ETF position peaked at $35K in Q2 2015.
86 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2015.

Based on Lehman Financial Resources's 13F filing for Q4 2015, filed 17 Feb 2016.